Propensity score matched study of collagenase clostridium histolyticum versus limited fasciectomy, in patients with dupuytren's contracture

Trial Profile

Propensity score matched study of collagenase clostridium histolyticum versus limited fasciectomy, in patients with dupuytren's contracture

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Sep 2015

At a glance

  • Drugs Collagenase clostridium histolyticum (Primary)
  • Indications Dupuytren's contracture
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Sep 2015 New trial record
    • 01 Jul 2015 Results published in the Plastic and Reconstructive Surgery.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top